• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Desethyl chloroquine diphosphate Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5753002

Desethyl chloroquine diphosphate is the main deethyl metabolite of chloroquine. Chloroquine diphosphate is an inhibitor of autophagy and toll-like receptors (TLRs). Chloroquine diphosphate has anti-plasma activity. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Desethyl chloroquine diphosphate, Inhibitor
Full Product Name
Desethyl chloroquine diphosphate
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
487.81
Solubility
<1mg/ml refers to the product slightly soluble or insoluble
Formula
C16H28ClN3O8P2
SMILES
CC(NC1=CC=NC2=CC(Cl)=CC=C12)CCCNCC.O=P(O)(O)O.O=P(O)(O)O
CAS Number
247912-76-1
Target & IC50
Others
In Vitro
Intraperitoneal injection of chloroquine was used in wild-type and Huntington's disease (Q175/Q175) mice. LC-MS/MS is used to compare the levels of chloroquine and its metabolites in blood, brain and muscle tissue. The concentration of chloroquine is low (5-15M), but within 4-24 hours after the last use, it is more stable in brain tissue than blood or muscle. The level of deethylchloroquine, the active chloroquine metabolite in the muscle and blood, decreased 24 hours after injection, while the level of deethylchloroquine in the brain was lower, rising slightly during the same period.

Product References and Citations for Desethyl chloroquine diphosphate, inhibitor

Ajayi FO, et al. Comparison of the partitioning in vitro of chloroquine and its desethyl metabolites between the erythrocytes and plasma of healthy subjects and those with falciparum malaria. Afr J Med Med Sci. 1989 Jun;18(2):95-100.
Ajayi FO, et al. Comparison of the partitioning in vitro of chloroquine and its desethyl metabolites between the erythrocytes and plasma of healthy subjects and those with falciparum malaria. Afr J Med Med Sci. 1989 Jun;18(2):95-100.
Vodicka P, et al. Assessment of chloroquine treatment, for modulating autophagy flux in brain of WT and HD mice. J Huntingtons Dis. 2014;3(2):159-74.
Vodicka P, et al. Assessment of chloroquine treatment, for modulating autophagy flux in brain of WT and HD mice. J Huntingtons Dis. 2014;3(2):159-74.
Said A, et al. Chloroquine promotes IL-17 production by CD4+ T cells via p38-dependent IL-23 release by monocyte-derived Langerhans-like cells. J Immunol. 2014 Dec 15;193(12):6135-43.
Said A, et al. Chloroquine promotes IL-17 production by CD4+ T cells via p38-dependent IL-23 release by monocyte-derived Langerhans-like cells. J Immunol. 2014 Dec 15;193(12):6135-43.

Other Notes

Small volumes of Desethyl chloroquine diphosphate, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Desethyl chloroquine diphosphate purchase

MBS5753002 is an inhibitor targeting Desethyl chloroquine diphosphate.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000